Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shoulder InnovationsFRA:VB3 +2.86%18 Cash Ratio is 8.80 as of Mar. 2026, which is 15% above its 10-year median of 7.66. GuruFocus rates FRA:VB3 with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 841 Medical Devices & Instruments companies, Shoulder Innovations ranks better than 95.12% on this metric.
Shoulder Innovations has a Cash Ratio of 8.80. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for Shoulder Innovations's Cash Ratio or its related term are showing as below:
FRA:VB3'
s Cash Ratio Range Over the Past 10 Years
Min: 1.97 Med: 7.66 Max: 9.14
Current: 8.8
During the past 3 years, Shoulder Innovations's highest Cash Ratio was 9.14. The lowest was 1.97. And the median was 7.66.
FRA:VB3's Cash Ratio is ranked better than 95.12% of 841
companies
in the Medical Devices & Instruments industry
Industry Median: 0.97
vs FRA:VB3: 8.80
Shoulder Innovations (FRA:VB3) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Shoulder Innovations Cash Ratio Related Terms
Shoulder Innovations Cash Ratio Historical Data
* Premium members only.
The historical data trend for Shoulder Innovations's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Shoulder Innovations's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shoulder Innovations Cash Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shoulder Innovations's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Shoulder Innovations's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shoulder Innovations (FRA:VB3) has a Cash Ratio of 8.80 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Shoulder Innovations and its competitors. This is 15% above median its historical median of 7.66. Over the past decade, Shoulder Innovations' Cash Ratio has ranged from 1.97 to 9.14. According to the industry distribution chart, Shoulder Innovations ranks #41 out of 841 companies in the Medical Devices & Instruments industry, placing it in the top 4.9%.
Is Shoulder Innovations' Cash Ratio too high?
Shoulder Innovations' current Cash Ratio of 8.80 is 15% above median its 10-year median of 7.66. Over the past 10 years, this metric has ranged from a low of 1.97 to a high of 9.14. The Medical Devices & Instruments industry median Cash Ratio is 0.97. Shoulder Innovations' value of 8.80 is 807.2% above this industry median. Based on the distribution chart, Shoulder Innovations ranks #41 out of 841 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shoulder Innovations has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Shoulder Innovations' Cash Ratio compare to MOBI and DCTH?
According to the Medical Devices & Instruments industry distribution chart, Shoulder Innovations ranks #41 out of 841 companies for Cash Ratio. This places Shoulder Innovations in the top 5% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.97. Shoulder Innovations' value of 8.80 is 807.2% above this benchmark. Historically, Shoulder Innovations' own Cash Ratio has ranged from 1.97 to 9.14 over the past decade. While the company's 10-year median is 7.66 vs. the industry median of 0.97, Shoulder Innovations has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Devices & Instruments company?
The median Cash Ratio among Medical Devices & Instruments companies is 0.97, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shoulder Innovations's current Cash Ratio of 8.80 is 807.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Shoulder Innovations and its competitors. For the Medical Devices & Instruments industry, the median Cash Ratio is 0.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shoulder Innovations's current Cash Ratio is 8.80, which is 15% above median its own 10-year median of 7.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shoulder Innovations stock overvalued right now?
Shoulder Innovations (FRA:VB3) has a current Cash Ratio of 8.80. The current Cash Ratio is 8.80, which is 15% above median its 10-year median of 7.66 and 807.2% above the Medical Devices & Instruments industry median of 0.97. Shoulder Innovations' overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Shoulder Innovations (FRA:VB3), the current Cash Ratio is 8.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
18GF Score
Get the complete analysis for FRA:VB3
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:VB3 has been successfully added to your 
